Deutsche Bank’s AN2 Therapeutics ANTX Stock Holding History

Deutsche Bank’s Portfolio ANTX Stock Details ANTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$125K	Buy	+25,838	New	+$111K	﹤0.01%	3423
2024 Q1	–	Sell	-39,472	Closed	-$809K	–	3613
2023 Q4	$809K	Buy	+39,472	New	+$660K	﹤0.01%	2132
2023 Q2	–	Sell	-6,815	Closed	-$67.3K	–	3809
2023 Q1	$67.3K	Buy	6,815 +2,026	+42%	+$22.5K	﹤0.01%	3474
2022 Q4	$45.6K	Buy	4,789 +2,903	+154%	+$38.9K	﹤0.01%	3602
2022 Q3	$33K	Sell	1,886 -310	-14%	-$3.61K	﹤0.01%	3684
2022 Q2	$17K	Buy	+2,196	New	+$29.1K	﹤0.01%	3954

Other funds holding ANTX

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Deutsche Bank's ANTX Position: Q2 2026 in Review

Deutsche Bank opened a new position in AN2 Therapeutics (ANTX) in Q2 2026: 25,838 shares worth $125K. The stake represents ﹤0.01% of the portfolio and ranks #3423 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ANTX as recently as Q4 2023.

Deutsche Bank first reported a position in ANTX in Q2 2022 and has held it in 6 quarters since. The position peaked at $809K in Q4 2023. 66 funds tracked by Wall St. Rank hold ANTX as of Q2 2026.

Deutsche Bank held 25,838 shares of AN2 Therapeutics worth $125K as of Q2 2026.
AN2 Therapeutics was a new Deutsche Bank position in Q2 2026.
AN2 Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3423 holding.
Deutsche Bank first reported a position in AN2 Therapeutics in Q2 2022 and has held it in 6 quarters since.
Deutsche Bank's AN2 Therapeutics position peaked at $809K in Q4 2023.
66 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.